Abacus Wealth Partners, LLC Zoetis Inc. Transaction History

Abacus Wealth Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 31, 2023	SELL	$181.39 - $234.03 $222,202 - $286,686	-1,225 Closed	0 $0
Q4 2021 May 31, 2023	BUY	$193.69 - $247.03 $237,270 - $302,611	1,225 New	1,225 $299 Million
Q3 2021 May 31, 2023	SELL	$189.29 - $209.69 $4,732 - $5,242	-25 Reduced 1.97%	1,245 $242 Million
Q2 2021 May 31, 2023	BUY	$155.9 - $187.99 $197,993 - $238,747	1,270 New	1,270 $237 Million
Q1 2021 May 31, 2023	BUY	$144.0 - $169.39 $192,528 - $226,474	1,337 New	1,337 $210 Million

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Abacus Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Abacus Wealth Partners, LLC with notifications on news.